For Research Purposes Only · Not For Human Consumption
Anti-Inflammatory Research
C-terminal α-MSH tripeptide (Lys-Pro-Val). Researched for NF-κB suppression, gut inflammation and mast-cell modulation.
Vial size
Quantity
£24.99
In stockInc. VAT · Add £25.01 more for free UK shipping
SSL encrypted · CoA published for this lot
Certificate of Analysis
KPV 10mg
The CoA you download is the exact certificate produced for this lot — no edits.
Storage & handling
Keep it stable, keep it sterile
KPV is the C-terminal tripeptide fragment (Lys-Pro-Val) of α-melanocyte stimulating hormone (α-MSH), retaining significant anti-inflammatory activity of the parent peptide while lacking pigmentary effects. Published research has documented NF-κB pathway suppression, mast-cell stabilisation and protective effects in models of inflammatory bowel disease and skin inflammation. ≥98% HPLC, third-party CoA.
KPV is the C-terminal tripeptide fragment (Lys-Pro-Val) of α-melanocyte stimulating hormone (α-MSH), retaining significant anti-inflammatory activity of the parent peptide while lacking pigmentary effects. Extensively researched for NF-κB suppression, mast-cell stabilisation and protective effects in inflammatory bowel disease and skin inflammation models.
UK Peptides supplies KPV 10mg as ≥98% HPLC lyophilised powder with a signed third-party Certificate of Analysis.
The 10mg vial supports extended research protocols. Published research covers:
Store the lyophilised vial at -20°C, sealed and protected from light. Refrigerate the reconstituted solution at 2–8°C and use within 28 days. Do not refreeze after reconstitution.
Every KPV 10mg lot is independently HPLC-UV tested to ≥98% purity by an accredited independent laboratory, with mass-spectrometry identity confirmation against the published molecular weight of 342.44 Da. The signed PDF Certificate of Analysis is supplied with every order and matches the vial lot number.
UK-stocked, same-day Manchester dispatch, third-party HPLC verification on every batch and Royal Mail Tracked 24 with insulated cold-chain packaging. Full lot traceability from vial sticker to signed CoA visible on this page.
The science, in depth
Mechanism, the published evidence and handling detail for KPV are covered in full in our research library — 6 referenced articles rather than a summary on a product page.
KPV is the C-terminal tripeptide (Lys-Pro-Val) of α-melanocyte-stimulating hormone (α-MSH). It retains a substantial fraction of α-MSH's documented anti-inflammatory activity in cell and animal models while lacking the pigmentary activity mediated by the full peptide's binding to MC1R.
Regulatory & compliance notice
This product is supplied strictly for in-vitro laboratory research. It is not a licensed medicine in the United Kingdom, is not approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency for human or veterinary use, and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page constitutes medical advice.
Last reviewed 22 July 2026.
Peer-referenced articles from our research library covering mechanism, evidence and handling.
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Research Article
Read article →
Every batch independently tested by an accredited independent laboratory before dispatch. The signed certificate for this lot is published on this page.
Legal notice
This product is sold strictly for in-vitro laboratory research purposes only. It is not approved for human or veterinary use, is not a drug, food, or cosmetic, and should not be misused as such. UK Peptides accepts no liability for misuse. By purchasing you confirm you are a qualified researcher aged 18 or over.
KPV 10mg
£24.99
